Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Found new possible treatments for hair loss.

Progesterone protects brain cells, but Provera does not.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Antiandrogen therapy helps treat genetic hair loss.

Melatonin shortens the hair growth cycle by increasing PDGFA gene expression.

ATP helps prevent skin damage from vandetanib by reducing stress.

The method effectively predicts new drug uses, including potential COVID-19 treatments.

Genetic profiling can improve androgenetic alopecia treatment by predicting drug response and minimizing side effects.

Glycyrrhizin may help regrow hair by activating a specific pathway.

Activating the GDNF-GFRα1-RET signaling pathway could potentially promote skin and limb regeneration in humans and could be used to treat hair loss and promote wound healing.

Low testosterone can cause a heart rhythm problem in men, but fixing it can prevent the issue.

Nanogels with hydrophobic modifications improve oral drug delivery for intestinal disease treatment.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

Hedgehog pathway inhibitors can treat certain aggressive cancers but face limitations like resistance and side effects.

The estradiol valerate/dienogest oral contraceptive helps with heavy periods, may improve acne and symptoms in PCOS, and doesn't affect sexual function.

Treating early puberty with hormone therapy may increase the risk of polycystic ovary syndrome in adults.

Gender-affirming hormone therapy affects metabolism differently based on treatment type.

Regulatory challenges make developing combination therapies in urology difficult and costly.

Letrozole may help prevent seizures by reducing certain hormone levels.

Combining a GnRH agonist with a low-dose oral contraceptive is more effective and safer for treating hirsutism than using either alone.

Total glucosides of paeony can help treat skin conditions but need more research for clinical use.

Diphencyprone initially increases mouse hair growth, then slows it, possibly due to changes in specific protein levels.

Certain proteins and their receptors are more active during the growth phase of human hair and could be targeted to treat hair disorders.

Mice lacking steroid 5α-reductase 2 show less aggression and better impulse control.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

The combination therapy reduced hirsutism in women with PCOD and was well-tolerated.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

New treatments for hair loss show promise but need more testing for effectiveness and safety.

The document concludes that hair transplantation and gene therapy may be important for future hair loss treatment.